全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
PLOS ONE  2012 

Evolutionary Determinants of Genetic Variation in Susceptibility to Infectious Diseases in Humans

DOI: 10.1371/journal.pone.0029089

Full-Text   Cite this paper   Add to My Lib

Abstract:

Although genetic variation among humans in their susceptibility to infectious diseases has long been appreciated, little focus has been devoted to identifying patterns in levels of variation in susceptibility to different diseases. Levels of genetic variation in susceptibility associated with 40 human infectious diseases were assessed by a survey of studies on both pedigree-based quantitative variation, as well as studies on different classes of marker alleles. These estimates were correlated with pathogen traits, epidemiological characteristics, and effectiveness of the human immune response. The strongest predictors of levels of genetic variation in susceptibility were disease characteristics negatively associated with immune effectiveness. High levels of genetic variation were associated with diseases with long infectious periods and for which vaccine development attempts have been unsuccessful. These findings are consistent with predictions based on theoretical models incorporating fitness costs associated with the different types of resistance mechanisms. An appreciation of these observed patterns will be a valuable tool in directing future research given that genetic variation in disease susceptibility has large implications for vaccine development and epidemiology.

References

[1]  Haldane JBS (1949) Disease and evolution. La Ricerca Scientifica 19: 2–11.
[2]  Haldane JBS (1949) The rate of mutation of human genes. Proceedings of the Eighth International Congress of Genetics, Hereditas 35: 267–273.
[3]  Haldane JBS (1932) The causes of evolution. London: Longmans, Green and co. 234 p.
[4]  Allison AC (1964) Polymorphism and natural selection in human populations. Cold Spring Harb Symp Quant Biol 29: 137–149.
[5]  Allison AC (1954) Protection afforded by sickle-cell trait against subtertian malarial infection. Br Med J 1: 290–294.
[6]  Allison AC, Clyde DF (1961) Malaria in african children with deficient erythrocyte glucose-6-phosphate dehydrogenase. Br Med J 1: 1346–1349.
[7]  Siniscalco M, Bernini L, Latte B, Motulsky AG (1961) Favism and thalassaemia in sardinia and their relationship to malaria. Nature 190: 1179–1180.
[8]  Bellamy R (2004) Susceptibility to infectious diseases: The importance of host genetics. Cambridge: Cambridge University Press. 398 p.
[9]  Burgner D, Jamieson SE, Blackwell JM (2006) Genetic susceptibility to infectious diseases: Big is beautiful, but will bigger be even better? Lancet Infect Dis 6: 653–663.
[10]  Casanova JL, Abel L (2007) Human genetics of infectious diseases: A unified theory. EMBO J 26: 915–922.
[11]  Hill AV (2001) The genomics and genetics of human infectious disease susceptibility. Annu Rev Genomics Hum Genet 2: 373–400.
[12]  Jepson A (1998) Twin studies for the analysis of heritability of infectious disease. Bull Inst Pasteur 96: 71.
[13]  Kimman TG (2001) Genetics of infectious disease susceptibility. Boston: Kluwer Academic Publishers. 247 p.
[14]  Hill AV (1998) The immunogenetics of human infectious diseases. Annu Rev Immunol 16: 593–617.
[15]  Picard C, Casanova JL, Abel L (2006) Mendelian traits that confer predisposition or resistance to specific infections in humans. Curr Opin Immunol 18: 383–390.
[16]  Kaslow RA, McNicholl J, Hill AVS (2008) Genetic susceptibility to infectious diseases. New York: Oxford University Press. 447 p.
[17]  Sorensen TI, Nielsen GG, Andersen PK, Teasdale TW (1988) Genetic and environmental influences on premature death in adult adoptees. N Engl J Med 318: 727–732.
[18]  Jacobson RM, Ovsyannikova IG, Targonski PV, Poland GA (2007) Studies of twins in vaccinology. Vaccine 25: 3160–3164.
[19]  Poland GA, Ovsyannikova IG, Jacobson RM (2009) Application of pharmacogenomics to vaccines. Pharmacogenomics 10: 837–852.
[20]  Poland GA, Ovsyannikova IG, Jacobson RM, Smith DI (2007) Heterogeneity in vaccine immune response: The role of immunogenetics and the emerging field of vaccinomics. Clin Pharmacol Ther 82: 653–664.
[21]  Poland GA, Ovsyannikova IG, Jacobson RM (2008) Personalized vaccines: The emerging field of vaccinomics. Expert Opin Biol Ther 8: 1659–1667.
[22]  Olsen SJ, Ungchusak K, Sovann L, Uyeki TM, Dowell SF, et al. (2005) Family clustering of avian influenza A (H5N1). Emerg Infect Dis 11: 1799–1801.
[23]  Pitzer VE, Olsen SJ, Bergstrom CT, Dowell SF, Lipsitch M (2007) Little evidence for genetic susceptibility to influenza A (H5N1) from family clustering data. Emerg Infect Dis 13: 1074–1076.
[24]  Jorgensen G (1974) Erbfaktoren bei h?ufigen Krankheiten. Krankheiten mit multifaktorieller (polygener) Determination. In: Vogel F, editor. Handbuch der allgemeinen Pathologie. Berlin: Springer-Verlag. pp. 581–665.
[25]  Gedda L, Rajani G, Brenci G, Lun MT, Talone C, et al. (1984) Heredity and infectious diseases: A twin study. Acta Geneticae Medicae et Gemellologiae 33: 497.
[26]  Boots M, Haraguchi Y (1999) The evolution of costly resistance in host-parasite systems. Am Nat 153: 359–270.
[27]  Jeffery KJ, Bangham CR (2000) Do infectious diseases drive MHC diversity? Microbes Infect 2: 1335–1341.
[28]  Apanius V, Penn D, Slev PR, Ruff LR, Potts WK (1997) The nature of selection on the major histocompatibility complex. Crit Rev Immunol 17: 179–224.
[29]  Hughes AL, Nei M (1992) Models of host-parasite interaction and MHC polymorphism. Genetics 132: 863–864.
[30]  Spurgin LG, Richardson DS (2010) How pathogens drive genetic diversity: MHC, mechanisms and misunderstandings. Proc Biol Sci 277: 979–988.
[31]  Bowers RG, Boots M, Begon M (1994) Life-history trade-offs and the evolution of pathogen resistance: Competition between host strains. Proc Biol Sci 257: 247–253.
[32]  Antonovics J, Thrall PH (1994) Cost of resistance and the maintenance of genetic-polymorphism in host-pathogen systems. Proc Biol Sci 257: 105–110.
[33]  Lenski RE, Levin BR (1985) Constraints on the coevolution of bacteria and virulent phage: A model, some experiments, and predictions for natural communities. Am Nat 125: 602.
[34]  Boots M, Begon M (1993) Trade-offs with resistance to a granulosis virus in the indian meal moth, examined by a laboratory evolution experiment. Funct Ecol 7: 528–534.
[35]  Kraaijeveld AR, Godfray HC (1997) Trade-off between parasitoid resistance and larval competitive ability in Drosophila melanogaster. Nature 389: 278–280.
[36]  Fellowes MD, Kraaijeveld AR, Godfray HC (1998) Trade-off associated with selection for increased ability to resist parasitoid attack in Drosophila melanogaster. Proc Biol Sci 265: 1553–1558.
[37]  Cotter SC, Kruuk LE, Wilson K (2004) Costs of resistance: Genetic correlations and potential trade-offs in an insect immune system. J Evol Biol 17: 421–429.
[38]  Biere A, Antonovics J (1996) Sex-specific costs of resistance to the fungal pathogen Ustilago violacea (Microbotryum violaceum) in Silene alba. Evolution 50: 1098–1110.
[39]  Clegg JB, Weatherall DJ (1999) Thalassemia and malaria: New insights into an old problem. Proc Assoc Am Physicians 111: 278–282.
[40]  Hill AV (1992) Molecular epidemiology of the thalassaemias (including haemoglobin E). Baillieres Clin Haematol 5: 209–238.
[41]  Boots M, Bowers RG (2004) The evolution of resistance through costly acquired immunity. Proc Biol Sci 271: 715–723.
[42]  Mealor MA, Boots M (2006) An indirect approach to imply trade-off shapes: Population level patterns in resistance suggest a decreasingly costly resistance mechanism in a model insect system. J Evol Biol 19: 326–330.
[43]  Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, et al. (2009) Finding the missing heritability of complex diseases. Nature 461: 747–753.
[44]  Lockhart AB, Thrall PH, Antonovics J (1996) Sexually transmitted diseases in animals: Ecological and evolutionary implications. Biol Rev Camb Philos Soc 71: 415–471.
[45]  Fumagalli M, Pozzoli U, Cagliani R, Comi GP, Bresolin N, et al. (2010) Genome-wide identification of susceptibility alleles for viral infections through a population genetics approach. PLoS Genet 6: e1000849.
[46]  Fumagalli M, Cagliani R, Pozzoli U, Riva S, Comi GP, et al. (2009) Widespread balancing selection and pathogen-driven selection at blood group antigen genes. Genome Res 19: 199–212.
[47]  Falconer DS, Mackay TFC (1996) Introduction to quantitative genetics. Essex: Longman. 464 p.
[48]  Grigoriu D, Delacrétaz J, Borelli D (1987) Medical mycology. Toronto: Huber. 474 p.
[49]  Holmes KK, Mardh P, Sparling PF, Wiesner PJ, Cates W Jr, et al. (1990) Sexually transmitted diseases. New York: McGraw-Hill, Inc. 1115 p.
[50]  John DT, Petri WA, Markell EK, Voge M, Markell EK, et al. (2006) Markell and Voge's medical parasitology. St. Louis: Saunders Elsevier. 463 p.
[51]  Kiple KF (1993) The Cambridge world history of human disease. Cambridge: Cambridge University Press. 1176 p.
[52]  Stansberry LR, Bernstein DI (2000) Sexually transmitted diseases: Vaccines, prevention and control. London: Academic Press. 468 p.
[53]  Turkington C, Ashby B (1998) Encyclopedia of infectious diseases. New York: Facts on File. 370 p.
[54]  Mandell GL, Douglas RG, Bennett JE, Dolin R (2005) Mandell, Douglas, and Bennett's principles and practice of infectious diseases. Philadelphia: Elsevier/Churchill Livingstone. 3662 p.
[55]  SAS Institute Inc (2002) SAS system for windows. 9.2.
[56]  R Development Core Team (2008) R: A language and environment for statistical computing. 2.11.1.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133